Comments to Drs. Bahji, Vazquez, and Zarate
- PMID: 33571795
- DOI: 10.1016/j.jad.2021.01.046
Comments to Drs. Bahji, Vazquez, and Zarate
Abstract
In the absence of head-to-head studies directly comparing the efficacy of intranasal esketamine to that of intravenous ketamine, valid conclusions regarding comparative efficacy cannot be made based on the existing data from trials using markedly differing study designs and patient populations.
Keywords: Depression; Esketamine; Ketamine; Major depressive disorder.
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.
Comment on
-
Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.J Affect Disord. 2021 Jan 1;278:542-555. doi: 10.1016/j.jad.2020.09.071. Epub 2020 Sep 23. J Affect Disord. 2021. PMID: 33022440 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources